{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T12:25:43Z","timestamp":1745238343108},"reference-count":0,"publisher":"Codon Publications","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["aei"],"abstract":"<jats:p>Background: The Mexican Guidelines for the diagnosis and treatment of urticaria have been published. Just before their launch, physicians\u2019 knowledge was explored relating to key issues of the guidelines.\nObjective: The aim of this study was to investigate the opinion of medical specialists concern-ing urticaria management.Methods: A SurveyMonkey\u00ae survey was sent out to board-certified physicians of three medical specialties treating urticaria. Replies were analyzed per specialty against the evidence-based recommendations.\nResults: Sixty-five allergists (ALLERG), 24 dermatologists (DERM), and 120 pediatricians (PED) sent their replies. As for diagnosis: ALERG 42% and PED 76% believe cutaneous mastocytosis, urticarial vasculitis, and hereditary angioedema are forms of urticaria, versus DERM 29% (P &lt; 0.005). Most of the specialties find that the clinical history and physical examination are enough to diagnose acute urticaria, except DERM 45% (P &lt; 0.01). DERM 45% believe laboratory-tests are necessary, as opposed to &lt;15% ALLERG\u2013PED (P &lt; 0.005). However, PED 69% did not know that the most frequent cause of acute urticaria in children is infections, versus ALLERG\u2013 DERM 30% (P &lt; 0.005). Many erroneously do laboratory testing in physical urticaria and ALLERG 51%, DERM 59%, and PED 37% do extensive laboratory testing in chronic spontaneous urticaria (CSU); many more PED 59% take Immunoglobulin G (IgG) against foods (P &lt; 0.005). More than half of non-allergists do not know about autologous serum testing nor autoimmunity (P &lt; 0.05). As for treatment, there were a few major gaps: when CSU was controlled, &gt;75% prescribed antihistamines pro re nata, and &gt;85% gave first-generation antiH1 for insomnia. Finally, &gt;40% of DERM did not know that cyclosporine A, omalizumab, or other immunosuppressants could be used in recalcitrant cases.\nConclusion: Specialty-specific continuous medical education might enhance urticaria management.<\/jats:p>","DOI":"10.15586\/aei.v49i1.26","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T04:27:01Z","timestamp":1610166421000},"page":"87-94","source":"Crossref","is-referenced-by-count":2,"title":["CME suggestions for pediatricians, allergists, and dermatologists, directed by an online survey on urticaria knowledge"],"prefix":"10.15586","volume":"49","author":[{"given":"Cesar Fireth","family":"Pozo-Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e","family":"Larenas-Linnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna Danielle","family":"Cardoza Arteche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","published-online":{"date-parts":[[2021,1,8]]},"container-title":["Allergologia et Immunopathologia"],"original-title":[],"link":[{"URL":"http:\/\/www.all-imm.com\/index.php\/aei\/article\/download\/26\/46","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.all-imm.com\/index.php\/aei\/article\/download\/26\/47","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.all-imm.com\/index.php\/aei\/article\/download\/26\/48","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.all-imm.com\/index.php\/aei\/article\/download\/26\/46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T04:41:10Z","timestamp":1610426470000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.all-imm.com\/index.php\/aei\/article\/view\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,8]]}},"URL":"https:\/\/doi.org\/10.15586\/aei.v49i1.26","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]}}}